CLASS II ONGOING Device recall · Reported 30 Aug 2023 · FDA Enforcement Report

FilmArray Pneumonia Panel (Pneumo) recalled by BioFire Diagnostics

BioFire Diagnostics is recalling FilmArray Pneumonia Panel (Pneumo), distributed in 21 states. The recall was initiated on 8 May 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesPouch Lot # 2NBT22 /Kit # 2187822 ;UDI-DI: UDI: 00815381020482
Quantity recalled24 Kits (30 pouches/kit)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2440-2023
FDA event ID
92397
Recalling firm
BioFire Diagnostics, Salt Lake City, UT
Classification
Class II
Status
Ongoing
Recall initiated
8 May 2023
FDA classified
21 Aug 2023
Reported
30 Aug 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

8 May 2023Recall initiated by company
21 Aug 2023Classified by FDA+105 days
30 Aug 2023Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to manufacturing issue, panels may result in false negative results.

Product as listed by the FDA

FilmArray Pneumonia Panel (Pneumo), REF: RFIT-ASY-0145, For FILMARRAY systems, CE 2797, IVD, Rx Only

Where it was distributed

US: CA CO CT FL GA IA IL IN LA MA MI MO MT NC NE NJ NM NY OH OK PA TN UT WV OUS: Canada, India, Japan, Singapore, Colombia

CaliforniaColoradoConnecticutFloridaGeorgiaIowaIllinoisLouisianaMassachusettsMichiganMissouriMontanaNorth CarolinaNebraskaNew JerseyNew MexicoNew YorkPennsylvaniaTennesseeUtah

Questions about this recall

Why was it recalled?

Due to manufacturing issue, panels may result in false negative results.

Which lots are affected?

Pouch Lot # 2NBT22 /Kit # 2187822 ;UDI-DI: UDI: 00815381020482

Where was it sold?

US: CA CO CT FL GA IA IL IN LA MA MI MO MT NC NE NJ NM NY OH OK PA TN UT WV OUS: Canada, India, Japan, Singapore, Colombia

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 92397

This product is part of a recall event; the main page for the event is BioFire Respiratory Panel 2.1 (RP2.1) recalled by BioFire Diagnostics.

ReportedClassRecallCompanyReasonWhere
CLASS IIBioFire Respiratory Panel 2.1 (RP2.1) recalled by BioFire DiagnosticsBioFire DiagnosticsOther21 states

More recalls from BioFire Diagnostics

All 47

Other Other Medical Devices recalls

All 13,929